Searched for
POMALIDOMIDE
Stocks in news: JSW Infra, Dixon Technologies, RIL, Natco Pharma, M&MMarkets experienced sharp selling pressure, nearing a key technical support level. Several companies like JSW Infra, Dixon Technologies, RI...- NATCO Pharma launches generic blood cancer treatment medicine in USNATCO Pharma has launched generic Pomalidomide capsules in the US. This drug treats blood and bone marrow cancer. It is a generic version o...
- GSK blood cancer drug nearly halves risk of death in late-stage trialIn the trial of 302 patients with relapsed or difficult-to-treat multiple myeloma, 71% of those who received Blenrep in combination with th...
- Stocks in news: Adani Enterprises, Adani Ports, Coffee Day, Siemens, IRB InfraIRB Infrastructure Developers, IRB Infrastructure Trust, have collectively reported the toll revenue of Rs 417 crore for the month of Augus...
- Natco Pharma, others sued in US for generic cancer drugThe company believes this matter is without merit, Natco Pharma said in a statement. Breckenridge is the abbreviated new drug application (...
- Stocks in the news: Axis Bank, Tata Motors, Adani Green, HUL, Lupin, Tata Power and NykaaAdani Green, Eicher Motors, Apollo Hospitals, Page Industries, Zomato, Trent, Jindal Steel , Indian Hotels, ConCor, Samvardhana Motherson a...
- Natco Pharma's marketing partner gets USFDA nod for cancer treatment drug"Breckenridge Pharmaceutical Inc. has received final approval for its abbreviated new drug application (ANDA) for Pomalidomide Capsules fro...
- Buy Aurobindo Pharma, target Rs 920: Phillip Capital (India)Buy Aurobindo Pharma at a price target of Rs 920.
- Natco Pharma launches generic blood cancer drug in IndiaNatco has launched pomalidomide capsules in strengths of 1 mg, 2 mg and 4 mg in India.
Load More
